RSV respiratory syncytial virus vaccine (single Dose) (VACRSVGSK)
*Please note that for all vaccine services, if you need to receive the vaccination on a specific day or time slot, please call 3970 8888 to inquire with customer service whether that time can be arranged, then proceed with payment and confirm the appointment with customer service.
RSV Poses a Fatal Threat: Mortality Rate as High as 17.6%! (1)
RSV, or Respiratory Syncytial Virus, is a common and highly contagious virus. However, there is still no targeted medication available, making early prevention—such as vaccination—crucial. Elderly individuals with chronic illnesses are considered a high-risk group due to weaker immunity. Once infected, they may experience worsened chronic conditions, leading to severe complications, hospitalization, or even death. (2)(3)(4) Common complications include pneumonia, acute bronchitis, heart failure, acute kidney failure, and metabolic disorders. (5)(6)(7)
If already infected with RSV, the likelihood of contracting influenza doubles (9)##, resulting in a dual attack from RSV and influenza, which increases the mortality rate by 4 times. (8)**#
AREXVY Vaccine: Effective Protection Against RSV
AREXVY is a vaccine designed to effectively prevent lower respiratory tract diseases caused by RSV:
1. Suitable for all individuals aged 60 or above.
2. The only RSV vaccine approved for high-risk individuals aged 50 to 59. (10)(11)
3. Outstanding Preventive Effectiveness of RSV for Individuals Aged 50 or Above:
82.6% effectiveness in preventing lower respiratory tract diseases caused by RSV.^
94.6% effectiveness in preventing RSV-related lower respiratory tract diseases in individuals with at least one underlying condition^ (e.g., COPD, asthma, chronic respiratory/lung diseases, chronic heart failure, diabetes, or advanced liver or kidney disease).
References:
(1) Zhang Y et al. Influenza Other Respir Viruses 2020;14:483-490.
(2) RSV in Older Adults and Adults with Chronic Medical Conditions. CDC 2022:1-2.
(3) CHP. Respiratory Syncytial Virus Infection. Available at: https://www.chp.gov.hk/en/healthtopics/content/24/36.html. Accessed Mar 2025.
(4) Kodama F, et al. Infect Dis Clin North Am. 2017:31(4):767-790.
(5) Lee N, et al. Clin Infect Dis. 2013;57(8):1069-1077.
(6) Tseng HF, et al. J Infect Dis. 2020;222(8):1298-1310.
(7) Chan PKS, et al. Medicine. 2015 Nov;94(46):1-11.
(8) Zhang Y, et al. J Clin Virol. 2020;133:104685.
(9) Waterlow NR, et al. BMC Med. 2023:21:441.
(10) Arexvy Prescribing Information. GSK Hong Kong.
(11) Drugs Database, Drug Office, Hong Kong. Available at: https://www.drugoffice.gov.hk/eps/do/en/consumer/search_drug_database2.html. Accessed Mar 2025.
Notes:
**A retrospective study (2017–2019) analyzed clinical outcomes of hospitalized adult patients infected with RSV, influenza, or both.
##A prospective longitudinal study (2016–2018) evaluated the risks of single RSV or influenza infection and dual infection.
#Comparing with single RSV infection
^Data provided by GSK UK.
- AREXVY Vaccine combines the RSVPreF3 antigen with the AS01E adjuvant system. It is specifically designed to induce a rapid and long-lasting humoral and cellular immune response, providing protection for the elderly.
Manufacturer:
- GSK
- All individuals aged 60 or above.
- High-risk individuals aged 50 to 59.
High-Risk Individuals Include:
Those with chronic illnesses, such as chronic obstructive pulmonary disease (COPD), asthma, cardiovascular disease, diabetes, chronic kidney disease, or liver disease.
Not applicable to persons
- Individuals with allergic reactions
- Patients with bleeding disorders or those on anticoagulants
- Individuals experiencing a fever
- If you have any concerns about the health status, it is advisable to consult a doctor before vaccination.
Shau Kei Wan- Perfect Life Medical Centre
Address: Shop 39, Aldrich Bay Shopping Centre, Aldrich Bay, Shau Kei Wan, Hong Kong
Tin Hau - Human Health Medical Centre
Address: G/F, Pak Lee Building, 6-8 King's Road, Hong Kong
Yau Tong Station - Human Health Medical Centre Yau Tong Station
Address: Shop 6, Yau Tong MTR Station, Kowloon
Ngau Tau Kok - Human Health Medical Centre
Address: Shop B3, G/F, Wai King Building,
No.1 Jordan Valley North Road, Ngau Tau Kok, Kowloon
Hung Hom- Human Health Medical Centre
Address: No. 30B, G/F, Whampoa Sun Chuen, Tak Man Street, Hung Hom, Kowloon
Kwun Tong Po Tat - Human Health Medical
Centre
Address: Shop 119, Po Tat Shopping Centre,
Po Tat Estate, Sau Mau Ping, Kwun Tong, Kowloon
Ma On Shan - Human Health Medical Centre
Address: G13A, G/F, MOSTown, No.628 Sai Sha Road, Ma On Shan, New Territories
Tsuen Wan Market Street- Human Health
Medical Centre
Address: Shop A1, G/F, Lin Ping House, 15-19 Tsuen Wan Market Street, Tsuen Wan, New
Territories
Tin Shui Wai - Human Health Medical Centre
Address: Shop NG18, G/F, T TOWN NORTH, Tin Yuet Estate, 33 and 39 Tin Wah Road, Tin Shui Wai, New Territories
Tung Chung Station- Human Health Integrated Medical Centre
Address: Shop 20, Tung Chung MTR Station, New Territories
Tai Po Fortune Plaza- Human Health Medical Centre
Address: Shop 28B, G/F, Fortune Plaza, 4 On chee Road, Tai Po, New Territories
If customer purchase this vaccine plan, please pay attention to the following vaccination instructions:
- Human Health will contact the customer within 2 working days after successful payment. Customers can also call hotline at 3970 8888 for booking. (Operation hours: Monday to Saturday: 9:00a.m.– 7:00p.m.)
- Vaccination must be scheduled within 6 months of purchase; no refunds will be issued for expired appointments.
- Same-day appointments are not accepted. Please schedule your vaccination at least 3 working days in advance.
- Customer who has allergic reactions to vaccine ingredients should not receive the injection.
- If customer have a fever or are taking antibiotics on the day of injection, it is recommended to delay the injection.
- If customer is pregnant or breastfeeding, or are receiving drug treatment (such as chemotherapy, steroids, etc.), customer should consult a doctor for advice and guidance before receiving injections.
- If customer is taking medicine but are not sure whether customer can receive the vaccine, it is recommended to consult a doctor first or bring the relevant medicine to the medical staff for examination on the day of injection before deciding whether it is suitable for the injection.
- If after assessment by the doctor, customer is not suitable for the vaccine injection, customer will need to pay the doctor's consultation fee of HK$300 - $350. The difference will be refunded. The detailed charges will be based on the arrangements of the medical center.